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The emergence of carbapenem-resistant Klebsiella pneumoniae (CRKP) often
responsible for numerous hospital-associated outbreaks has become an important
public health problem. From January 2013 to February 2014, a total of 41 non-
duplicate K. pneumoniae isolates with carbapenem resistance, were collected at a
tertiary teaching hospital in Nanchang, central China. Among 41 K. pneumoniae
isolates, 28 were isolated from hospitalized patients including 19 from the patients
in surgery intensive care unit (SICU) and 13 were isolated from ventilators. Twenty-
four of 28 patients infected by CRKP have been submitted to mechanical ventilation
using ventilator. More than 95% of the CRKP isolates were resistant to 13
antimicrobials tested. All CRKP isolates were confirmed as carbapenemase producer
and were positive for blaKPC 2, with one positive for both blaKPC and bla .− −2 NDM−1
All carbapenemase-producing isolates harbored at least one of extended spectrum
β-lactamase genes tested, among which 95.1% (39/41) of the tested isolates were
found to harbor both blaCTX M and bla , Of note, one isolate harbored− −24 KPC−2
simultaneously two carbapenemase genes (blaKPC−2 and blaNDM−1) and two ESBL
genes (blaCTX−M−3 and blaTEM−104). To the best of our knowledge, coexistence of
blaKPC in−2 and blaCTX M one− −24 isolate is first reported. MLST results showed that 41
CRKP isolates belonged to four sequence types (STs) including ST11, novel ST1854,
novel ST1855, and ST1224. PFGE results displayed three PFGE clusters. Thirty-
eight ST11 CRKP isolates (92.7%, 38/41) including all 13 isolates from ventilators
and 25 isolates from patients from seven wards (18 from SICU) belonged to same
PFGE cluster, indicating these isolates were clonally related. Fifteen isolates have an
identical undistinguished pattern (100% similarity) forming a single clonal population.
Moreover, this clone was exclusively linked to the cases attended in SICU and linked
to the Ventilators. Additionally, the other SICU cases were linked to closely related
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clones (similarity greater than 95%). These data indicated that the occurrence of a
clonal outbreak associated with ventilators has been found. In conclusion, outbreak by
ventilator-associated ST11 K. pneumoniae with co-production of CTX-M-24 and KPC-2
is found in a SICU of a tertiary teaching hospital in central China.
Keywords: K. pneumoniae, carbapenemase, KPC-2, outbreak, ST11
INTRODUCTION
Klebsiella pneumoniae is an opportunistic pathogen associated
mainly with pneumonia, bloodstream infections, and urinary
tract infections. K. pneumoniae frequently exhibits multi-
resistance to antimicrobial agents (Bratu et al., 2005).
Carbapenems are often used for the treatment of clinical
infections caused by this clinically important pathogen with
multi-resistance to antimicrobial agents. However, the resistance
of K. pneumoniae to carbapenems has been increasing (Gupta
et al., 2011). As frequently carry additional antimicrobial
resistance genes, K. pneumoniae isolates with carbapenem
resistance often exhibit resistance to other non-β-lactam
antimicrobial agents (Temkin et al., 2014). The emergence
of carbapenem-resistant K. pneumoniae has become an
important public health problem. The mechanism of resistance
to carbapenems is mainly associated with production of
carbapenemases (Nordmann and Poirel, 2002). Acquired
carbapenemases encoded by transferable genes located
in mobile elements including plasmids and transposons
disseminate rapidly among different strains and species among
Enterobacteriaceae (Temkin et al., 2014). K. pneumoniae
carbapenemases (KPCs) and class B metallo-β-lactamases
(MBLs) are found to be main carbapenemases in K. pneumoniae.
In China, KPC-2 is a predominant carbapenemase and has
been widely recognized in many species of Enterobacteriaceae
including K. pneumoniae, Serratia marcescens, Escherichia coli,
and Enterobacter cloacae (Cai et al., 2008; Wu et al., 2010). In
2009, a novel MBL, New Delhi metallo-lactamase 1 (NDM-1)
initially identified in a K. pneumoniae isolate represents a
new challenge for the treatment of infectious diseases (Yong
et al., 2009; Kumarasamy et al., 2010). Dissemination of
KPC-2 producing K. pneumoniae has been found in many
Chinese hospitals (Yang et al., 2013; Hu et al., 2014). Recent
reports showed that sequence type 258 (ST258) is the most
prevalent clone contributing to the worldwide spread of
KPC-producing K. pneumoniae and is the cause of numerous
hospital-associated outbreaks (Kitchel et al., 2009; Hammerum
et al., 2010; Marquez et al., 2014). In China, the dominant clone
of KPC-producing K. pneumoniae is ST11 which is closely
related to ST258 (Qi et al., 2011). Although many reports
have identified KPC-2 producing K. pneumoniae, outbreak by
ventilator-associated KPC-2 producing K. pneumoniae in China
was limited. The aim of the present study was to investigate
the dissemination of ventilator-associated K. pneumoniae with
carbapenem resistance in a tertiary teaching hospital in central
China. We demonstrated a outbreak by ventilator-associated
ST11 K. pneumoniae with co-production of CTX-M-24 and
KPC-2.
MATERIALS AND METHODS
Isolation and Identification of Bacterial
Strains
From January 2013 to February 2014, a total of 41 non-
duplicate K. pneumoniae isolates with carbapenem resistance
were collected, among which 28 were isolated from hospitalized
patients and 13 were isolated from ventilators in a tertiary
teaching hospital in Nanchang, China. The 28 isolates of CRKP
were isolated from sputum (22), blood (2), ascites (1), bile (1),
urine (1), and bronchoalveolar lavage fluid (1) of the patients.
The first isolation of every patient was selected for further
investigation. Among 28 patients infected by CRKP, 19, 3, and 2
were isolated from surgical intensive care unit (SICU), respiratory
ward and gastroenterology ward, respectively. Pulmonary
infection was found among 22 of 28 patients, while bloodstream
infection was found in two patients. The remaining four
isolates were isolated from four patients in general surgery
ward, neurosurgery ward, urology ward, and nephrology ward,
respectively. Twenty-four of 28 patients have been submitted to
mechanical ventilation using ventilator. Consequently, 13 CRKP
isolates were isolated from the ventilators used for the patients
mentioned above. The patients were primarily elderly (median
age of 62.5 years old, average of 23–97 years old) and subjected to
multiple underlying diseases. Twenty-six of 28 patients have been
submitted to multiple invasive treatment procedures, such as
mechanical ventilation (24/26), venipuncture and catheterization
(17/26), urinary catheterization (12/26). Moreover, all patients
received multiple antimicrobials treatment in the course of
hospitalization. Ventilators were sampled by rotating sterile,
cotton-tipped swabs inserted into the bottom of the tubes. The
bacterial isolates from sputum specimens growing more than
three fourths of the plate by quantitative culture were considered
to be responsible for pulmonary infection. K. pneumoniae isolates
were identified by a Vitek-2 microbiology analyzer (bioMérieux,
Marcy l’Etoile, France) in accordance with the manufacturer’s
instructions. Escherichia coli ATCC 25922 was used as the control
strain. The Ethics Committee of the first Affiliated Hospital of
Wenzhou Medical University exempted this study from review
because the present study focused on the bacteria.
Antimicrobial Susceptibility Testing
Antimicrobial susceptibilities were determined initially by
using Gram-negative susceptibility (GNS) cards on the Vitek
system (bioMérieux, Marcy l’Etoile, France). Then multidrug
resistance profiles were further evaluated by the disk diffusion
test using commercial disks including minocycline (30 µg),
tetracycline (30 µg), piperacillin (100 µg), piperacillin/sulbactam
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(110 µg), cefotaxime (30 µg), ceftazidime (30 µg), cefepime
(30 µg), aztreonam (30 µg), cefoxitin (30 µg), imipenem
(10 µg), meropenem (10 µg), trimethoprim/sulfamethoxazole
(1.25/23.75 µg), amikacin (30 µg), gentamicin (10 µg),
ciprofloxacin (5 µg), and levofloxacin (5 µg), in accordance with
the criteria recommended by Clinical and Laboratory Standards
Institute [CLSI] (2014). Escherichia coli ATCC 25922 was used as
quality control strain for antimicrobial susceptibility testing.
Detection of β-Lactamases
The carbapenemases produced by CRKP isolates were
determined by modified Hodge test recommended by Clinical
and Laboratory Standards Institute [CLSI] (2014). Extended
spectrum beta lactamases (ESBLs) were tested among all CRKP
isolates by the CLSI-recommended confirmatory double disk
combination test (Clinical and Laboratory Standards Institute
[CLSI], 2014).
Investigation of Resistance Genes
The carbapenemase genes responsible for carbapenem resistance,
including blaKPC, blaGES, blaSPM , blaIMP, blaVIM, blaSPM , and
blaNDM , were detected using PCR and DNA sequencing as
described previously (Queenan and Bush, 2007; Nordmann
et al., 2011). ESBLs genes were detected in accordance with
the method described previously (Andrade et al., 2010). PCR
products were analyzed by electrophoresis in 1% agarose gels and
were sequenced on both strands.
Bacterial Clonal Relatedness
Pulsed-field gel electrophoresis (PFGE) was established using
XbaI digestion for 4 h at 37◦C and electrophoresis in agarose gels
for 19 h at 14◦C, 120◦, with switch times of 6 and 36 s at 6 V/cm,
Bio-Rad CHEF III system. Comparison of the PFGE patterns
was performed with Bionumerics software (Applied Maths, Sint-
Martens-Latem, Belgium) using the Dice Similarity coefficient.
Clusters were defined as DNA patterns sharing more than 80%
similarity. Multi-locus sequence typing (MLST) was performed
with seven standard housekeeping loci (gapA, infB, mdh, pgi,
phoE, rpoB, and tonB) as described on the K. pneumoniae MLST
website1. Sequence types (STs) were identified using the online
database.
RESULTS AND DISCUSSION
Antimicrobial Susceptibility
All CRKP isolates showed multi-resistance to antimicrobials
tested. More than 95% of the CRKP isolates were resistant
to 13 antimicrobials tested, with 100% resistance to
piperacillin, piperacillin/tazobactam, ceftazidime, ceftriaxone,
cefotaxime, cefoperazone/sulbactam, cefepime, meropenem, and
ciprofloxacin. However, the susceptibility rates of these isolates
to other antimicrobials tested were high, with susceptibility
rates of 95.12% to tigecycline, 92.68% to minocycline, 85.37%
to tetracycline, and 85.37% to trimethoprim-sulfamethoxazole,
1http://www.pasteur.fr/recherche/genopole/PF8/mlst/Kpneumoniae.html
respectively. There was similar resistance pattern between the
CRKP isolates from ventilators and patients.
Detection of β-Lactamases and
Resistance Genes
All CRKP isolates were confirmed as carbapenemase producer
determined by the modified Hodge test. In accordance with
phenotypic results of carbapenemases, all carbapenemase-
producing isolates were positive for blaKPC−2, with one positive
for both blaKPC−2 and blaNDM−1 (Figure 1). The result of
the present study was similar to previous reports in which
blaKPC−2 was the predominant carbapenemase gene among
K. pneumoniae in China (Chen et al., 2011; Hu et al., 2012).
Other carbapenemase genes including blaGES, blaIMP, blaSPM ,
and blaVIM were not detected in any of the tested isolates. Our
previous report also found that 54.9%, (28/51) of carbapenem-
resistant Enterobacteriaceae isolates expressed blaKPC−2 (Hu
et al., 2014). In contrast, IMP and NDM type metallo-lactamases
were also found among K. pneumoniae clinical isolates in
China. IMP-4 was found among four K. pneumoniae clinical
isolates from neonates and three K. pneumoniae isolates from
the environment of neonate ICU (Yu et al., 2012). A high
prevalence rate (55.0%, 22/40) of MBLs including IMP-4, IMP-
8, and NDM-1 was found among CRKP isolates at a tertiary
teaching hospital in southeastern China (Li et al., 2014). Co-
production of different carbapenamases was also found among
clinically important organisms which poses a challenge for
infection control (Karthikeyan et al., 2010; Wei et al., 2011; Dortet
et al., 2012; Kumarasamy and Kalyanasundaram, 2012; Rimrang
et al., 2012). In the present study, coexistence of blaKPC−2
and blaNDM−1 was found in one CRKP isolate. More type
carbapenemases and co-production of different carbapenamases
were found among CPKP isolates in China, which should be of
concern.
Co-production of carbapenemases with other β-lactamases
results in resistance to nearly all clinically available β-lactams.
As carbapenemases are not inhibited by clavulanic acid,
co-production of ESBLs and carbapenemases can mask
identification of ESBLs by the CLSI-recommended double-
disk test. Detection of multiple β-lactamases produced by
Enterobacteriaceae in the clinical laboratory is challenging. In the
present study, all carbapenemase-producing isolates harbored
at least one of ESBL genes tested, among which blaCTX-M-24
92.7% (38/41), blaSHV-12 78.1% (32/41), blaTEM-104 7.3%,
(3/41), and blaCTX-M-3 2.4% (1/41) harbored (Figure 1).
Thirty-seven (85.37%) of 41 CRKP isolates were positive for
narrow spectrum lactamase gene, blaTEM−1. 95.1% (39/41) of
the tested isolates were found to harbor both blaCTX−M−24
and blaKPC−2, with 75.6% (31 isolates) with coexistence of
blaCTX−M−24, blaSHV−12, and blaKPC−2 (Figure 1). In particular,
two isolates with blaKPC−2 were positive for three ESBL
genes including blaCTX−M−24, blaSHV−12, and blaTEM−104
(Figure 1). Of note, one isolate harbored simultaneously two
carbapenemase genes (blaKPC−2 and blaNDM−1) and two ESBL
genes (blaCTX−M−3 and blaTEM−104; Figure 1). blaKPC−2 has
been found to coexist with various ESBL genes in one organism.
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FIGURE 1 | Dendrogram of patterns for carbapenem-resistant K. pneumonia isolates obtained by PFGE. SICU, surgical intensive care unit; BALF,
bronchoalveolar lavage fluid; ST, sequence type; ESBLs, extended-spectrum beta-lactamases.
However, to the best of our knowledge, coexistence of blaKPC−2
and blaCTX−M−24 in one organism is first reported.
Bacterial Clonal Relatedness
Multi-locus sequence typing results showed that 41 CRKP isolates
belonged to four STs including ST11, novel ST1854, novel ST855,
and ST1224 (Figure 1). PFGE results displayed three PFGE
clusters (Figure 1). Thirty-eight isolates (92.7%) including all
13 isolates from ventilators and 25 isolates from patients from
six wards belonged to ST11. In accordance with MLST results,
PFGE results also showed that 38 ST11 isolates belonged to same
PFGE cluster with more than 80% of similarity, indicating these
CRKP isolates were clonally related. Particularly, 15 isolates have
an identical undistinguished pattern (100% similarity) forming
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a single clonal population. Moreover, this clone was exclusively
linked to the cases attended in SICU and linked to the ventilators.
Additionally, the other SICU cases were linked to closely related
clones (similarity greater than 95%). These data indicated that the
occurrence of a clonal outbreak associated with ventilators has
been found.
Although the isolate harboring both blaKPC−2 and blaNDM−1
was also from surgery ICU, it belonged to a novel ST, ST1855,
which was a two-locus variant of ST11. The ST1855 isolate
belonged to a specific PFGE cluster different from the PFGE
cluster representing for ST11 isolates, indicating that the ST1855
isolate was not clonally related to ST11 isolates. Another novel
ST, ST1854, was found in a isolate from the sputum of a patient
in respiratory ward. As ST1854 was a single-locus variant of
ST11, the ST1854 isolate and ST11 isolates belonged to same
PFGE cluster. The ST1224 isolate belonged to another PFGE
cluster. Among 25 patients infected by ST11 isolates, 18 were
from surgery ICU and other seven were from five wards. ST11,
a single-locus variant of ST258, was demonstrated to be the
predominant ST among KPC-2 producing K. pneumoniae in
China (Li et al., 2012). ST11 was also prevalent in Brazil (Andrade
et al., 2014). Although ST258 is the epidemic clone of KPC-2
producing K. pneumoniae worldwide, which has been reported
as dominant clone in USA (Kitchel et al., 2009), this important
clone has not been detected in China. Our data indicated that
the outbreak by KPC-2 -producing K. pneumonia has been
found in SICU of this tertiary teaching hospital in central China.
Other than surgery ICU, sparse ST11 isolates belonging to same
PFGE cluster were found in general surgery ward, Neurosurgery
ward, Urology ward, and Nephrology ward, indicating KPC-
2 -producing ST11 K. pneumoniae clone has disseminated at
this hospital. It is of concern that outbreak by this important
clone will occurred in other wards. Pulmonary infection caused
by ST11 CRKP was found among18 patients from surgery
ICU who were submitted to mechanical ventilation using the
ventilators contaminated by KPC-2 -producing K. pneumoniae.
Moreover, the CRKP isolates from patients from surgery ICU
were clonally related to the isolates from ventilators. Therefore,
we speculated that the outbreak by KPC-2 -producing ST11
K. pneumoniae clone was associated with ventilators. To control
the spread of carbapenemase-producing organism in hospital,
strict infection control measures such as reinforcement of
hand hygiene, contact precautions, disinfection of equipments,
disinfection of contaminated environment around patients
should be carried out.
CONCLUSION
An outbreak caused by ventilator-associated ST11 K. pneumoniae
with co-production of CTX-M-24 and KPC-2 has been found in
a surgery ICU of a tertiary teaching hospital in central China.
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